Transcranial Focused Ultrasound Targeting the Default Mode Network for the Treatment of Depression
Jessica N Schachtner,Jacob F Dahill-Fuchel,Katja E Allen,Christopher R. Bawiec,Peter J Hollender,Sarah B Ornellas,Soren D Konecky,Achal S Achrol,John JB Allen
DOI: https://doi.org/10.1101/2024.05.16.24307494
2024-05-17
Abstract:Importance: Up to 50% of individuals fail to respond to current depression treatments. Repetitive negative thought and default mode network hyperconnectivity are central in depression and can be targeted using novel neuromodulation techniques.
Objective: This study assessed whether noninvasive transcranial focused ultrasound to the default mode network can decrease depression symptoms and repetitive negative thought, and improve quality of life.
Design: This open label case series began in August 2023, with a six-month follow-up period (current).
Setting: A community-based study at the University of Arizona.
Participants: Twenty individuals aged 18 to 45 were enrolled from among 247 screened. Exclusion criteria included history of psychosis/mania, acute suicidality, MRI contraindications, pregnancy, and medical and neurological factors that may complicate diagnosis or brain function.
Intervention: Up to three weeks of transcranial ultrasound (11 sessions) targeting the anterior medial prefrontal cortex; ten minutes per session.
Main Outcomes and Measures: Depression severity (Beck Depression Inventory − II and the Hamilton Depression Rating Scale), repetitive negative thought (Perseverative Thinking Questionnaire), and quality of life (World Health Organization Quality of Life survey) were outcomes.
Results: This sample was young (mean 30.4 years ,SD = 10.0), predominantly female (75%), with moderate to severe depression and high comorbidity. Fifty percent of participants endorsed current psychiatric medication use. Ten percent of subjects dropped out of the study. Significant decreases in depression occurred on self report, 11.3 (p < 0.001, CI = −14.68, −8.15) and interview ratings, 4.3 (p < 0.001, CI = −6.21, −2.43). Repetitive Negative thought decreased by 8.53 (p <0.001, CI = −11.01, −5.79). Physical and psychological well being improved by 7.6 (p < 0.001, CI = 3.62, 11.63) and 11.9 points (p < 0.001, CI = 7.51, 16.21), respectively. Environment satisfaction increased by 5.0 (p = 0.001, CI = 2.24, 7.56).
Conclusions and Relevance: Transcranial ultrasound holds promise as a treatment for depression.
Trial Registration: Altering Default Mode Network Activity with Transcranial Focused Ultrasound to Reduce Depressive Symptoms (DMNtFUS). Registration number: 019782-00001 Clinical trials ID: URL: https://clinicaltrials.gov/study/ ?intr=Ultrasound&cond=depression&locStr=Arizona&country=United%20States&state=Arizona&rank=1